Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 13:13:858653.
doi: 10.3389/fgene.2022.858653. eCollection 2022.

The Causal Relationship Between Blood Lipids and Systemic Lupus Erythematosus Risk: A Bidirectional Two-Sample Mendelian Randomization Study

Mingzhu Wang  1 , Shuo Huang  1 , Xiaoying Lin  1 , Chengping Wen  1 , Zhixing He  1 , Lin Huang  1
Affiliations

The Causal Relationship Between Blood Lipids and Systemic Lupus Erythematosus Risk: A Bidirectional Two-Sample Mendelian Randomization Study

Mingzhu Wang et al. Front Genet. .

Abstract

Background: Although observational studies have demonstrated that blood lipids were associated with systemic lupus erythematosus (SLE), the causality of this association remains elusive as traditional observational studies were prone to confounding and reverse causality biases. Here, this study attempted to reveal the potential causal link between SLE and the levels of four blood lipids (HDL cholesterol, LDL cholesterol, TG, and TC). Methods: Bidirectional two-sample Mendelian randomization (MR) was employed to explore the unconfounded causal associations between the four blood lipids and SLE. In addition, regression-based Multivariate MR (MVMR) to quantify the possible mediation effects of blood lipids on SLE. After a rigorous evaluation of the quality of studies, the single-nucleotide polymorphisms (SNPs) associated with the four blood lipids were selected from the Global Lipids Genetic Consortium (GLGC) consisted of 188,577 individuals of European ancestry, and the SNPs related to SLE were selected from a large-scale genome-wide association study (GWAS) database named IEU GWAS. Subsequently, MR analyses were conducted with inverse-variance weighted (IVW), weighted median, weighted mode, simple mode, and MR-Egger regression. Sensitivity analyses were performed to verify whether heterogeneity and pleiotropy led to bias in the MR results. Results: Bidirectional two-sample MR results demonstrated that there was no significant causal association between SLE and the four blood lipids (When setting SLE as outcome, HDL cholesterol and SLE, IVW OR: 1.32, 95% CI: 1.05∼1.66, p = 1.78E-02; LDL cholesterol and SLE, IVW OR: 1.26, 95% CI: 1.04∼1.53, p = 2.04E-02; TG and SLE, IVW OR: 1.04, 95% CI: 0.71∼1.51, p = 8.44E-01; TC and SLE, IVW OR: 1.07, 95% CI: 0.89∼1.29, p = 4.42E-01; When setting SLE as exposure, SLE and HDL cholesterol, IVW OR: 1.00, 95% CI: 0.99∼1.01, p = 9.51E-01; SLE and LDL cholesterol, IVW OR: 0.99, 95% CI: 0.98∼1.00, p = 3.14E-01; SLE and TG, IVW OR: 0.99, 95% CI: 0.98∼1.00, p = 1.30E-02; SLE and TC, IVW OR: 0.99, 95% CI: 0.98∼1.00, p = 1.56E-01). Our MVMR analysis also provided little evidence that genetically determined lipid traits were significantly associated with the risk of SLE (HDL cholesterol and SLE, p = 9.63E-02; LDL cholesterol and SLE, p = 9.63E-02; TG and SLE, p = 8.44E-01; TC and SLE, p = 4.42E-01). Conclusion: In conclusion, these data provide evidence that genetic changes in lipid traits are not significantly associated with SLE risk in the European population.

Keywords: blood lipids; high density lipoprotein; low density lipoprotein; mendelian randomization; systemic lupus erythematosus; total cholesterol; triglycerides.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Results of the methods of MR analysis conducted to examine the relationship between blood lipids and SLE risk.
FIGURE 2
FIGURE 2
Scatter plots for MR analysis of the causal effect of blood lipids on SLE risk. (A) HDL cholesterol. (B) LDL cholesterol. (C) TC. (D) TG.
FIGURE 3
FIGURE 3
Results of the methods of MR analysis conducted to examine the relationship between SLE and blood lipids risk.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ajeganova S., Gustafsson T., Lindberg L., Hafström I., Frostegård J. (2020). Similar Progression of Carotid Intima-media Thickness in 7-year Surveillance of Patients with Mild SLE and Controls, but This Progression Is Still Promoted by Dyslipidaemia, Lower HDL Levels, Hypertension, History of Lupus Nephritis and a Higher Prednisolone Usage in Patients. Lupus Sci. Med. 7 (1), e000362. 10.1136/lupus-2019-000362 - DOI - PMC - PubMed
    1. Alsayed N., Almahmeed W., Alnouri F., Al-Waili K., Sabbour H., Sulaiman K., et al. (2022). Consensus Clinical Recommendations for the Management of Plasma Lipid Disorders in the Middle East: 2021 Update. Atherosclerosis 343, 28–50. 10.1016/j.atherosclerosis.2021.11.022 - DOI - PubMed
    1. Bazarbashi N., Miller M. (2022). Triglycerides. Med. Clin. North America 106 (2), 299–312. 10.1016/j.mcna.2021.11.006 - DOI - PubMed
    1. Burgess S., Davies N. M., Thompson S. G. (2014). Instrumental Variable Analysis with a Nonlinear Exposure-Outcome Relationship. Epidemiology 25, 877–885. 10.1097/EDE.0000000000000161 - DOI - PMC - PubMed
    1. Burgess S., Dudbridge F., Thompson S. G. (2016). Combining Information on Multiple Instrumental Variables in Mendelian Randomization: Comparison of Allele Score and Summarized Data Methods. Statist. Med. 35 (11), 1880–1906. 10.1002/sim.6835 - DOI - PMC - PubMed